SOTERIA Launches Cancer Hunt™ for Military and Veteran Patients

SAN DIEGO, Oct. 29, 2026 /CourierPR/ -- SOTERIA Precision Medicine Foundation, a California-based 501(c)(3) nonprofit, has launched Cancer Hunt™, a nationwide precision oncology program aimed at providing advanced support services to active-duty U.S. military and veteran service members facing a cancer diagnosis. The initiative is designed to remove barriers to leading-edge care by offering comprehensive genomic profiling and biomarker interpretation at no cost to the patient. The program also aims to reduce the administrative burden on treating oncologists and medical institutions.

Cancer Hunt™ is built on a straightforward but urgent premise: no service member or veteran fighting cancer should be denied access to life-saving genomic and medical insights due to insurance barriers or institutional delays, according to Julia Civardi, the founder and CEO of SOTERIA.

CAPT Rob Newson, SEAL, USN (RET), PhD, and Chief Community Officer of SOTERIA, highlighted the unique challenges faced by military service members and veterans.

The program operationalizes patient cancer support through a precision medicine framework designed to guide service members from initial uncertainty to data-driven information specific to their disease. Through Cancer Hunt™, SOTERIA deploys a multidisciplinary team comprised of oncology nurse navigators, PhD-level scientists, oncology specialists, and logistics coordinators. These experts work together to equip treating clinical teams with actionable molecular data, ensuring that patients receive the best possible care.

To ensure seamless collaboration with existing clinical providers, Cancer Hunt™ operates under clear principles of non-interference. This guarantees that patients receive continuous and uninterrupted care, maintaining the integrity of their treatment plans. Beyond immediate patient care, Cancer Hunt™ is building a critical repository of longitudinal population molecular and exposure data. By observing unique genomic signatures in active-duty and veteran populations, SOTERIA aims to establish clearer research links between military exposures and subsequent cancer development, driving preventative strategies for future service members.

SOTERIA is currently accepting patient referral partners and military and veteran patients with a cancer diagnosis to participate in the Cancer Hunt™ program. For more information, interested parties can visit the SOTERIA Precision Medicine Foundation’s website at www.soteriaprecisionmedicine.org or schedule a consult call with one of their nurse navigators. The organization also encourages healthcare providers and organizations to become referral partners to help expand the reach and impact of Cancer Hunt™.

The foundation’s commitment to expanding access to precision oncology for civilians, military service members, veterans, and underserved cancer populations is evident in its mission. By leveraging leading-edge molecular data, multidisciplinary experts, and dedicated oncology nurse navigation, SOTERIA empowers patients and their care teams with actionable data. This approach not only addresses the immediate needs of patients but also contributes to broader research efforts aimed at understanding and preventing cancer among military populations.